U.S. doctors are slowly turning to digital pathology to more accurately diagnose and treat cancer.
In April 2017, the U.S. Food and Drug Administration (FDA) approved digital microscopes for use in primary cancer diagnosis. This is the process of scanning conventional glass slides to create a virtual image. That image can be easily transferred anyplace in the world for a second opinion. Complete with a computer algorithm, the machine can also see patterns a pathologist may not be able to pick out.